scholarly journals Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction

2015 ◽  
Vol 100 (6) ◽  
pp. 667-679 ◽  
Author(s):  
Tharnwimol Inthachai ◽  
Suree Lekawanvijit ◽  
Sirinart Kumfu ◽  
Nattayaporn Apaijai ◽  
Wanpitak Pongkan ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Cardiac Function ◽  
Dipeptidyl Peptidase ◽  
Cardiac Remodelling ◽  
Chronic Myocardial Infarction ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor

scholarly journals Dipeptidyl peptidase-4 inhibitor prevents the progression of heart failure after myocardial infarction in mice

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P3305-P3305
Author(s):  
A. Kubota ◽  
H. Hasegawa ◽  
Y. Kameda ◽  
Y. Kobara ◽  
M. Hirose ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Heart Failure ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor

scholarly journals Sitagliptin decreases ventricular arrhythmias by attenuated glucose-dependent insulinotropic polypeptide (GIP)-dependent resistin signalling in infarcted rats

2016 ◽  
Vol 36 (2) ◽  
Author(s):  
Tsung-Ming Lee ◽  
Wei-Ting Chen ◽  
Nen-Chung Chang
Keyword(s):  
Myocardial Infarction ◽  
Ventricular Arrhythmias ◽  
Sympathetic Innervation ◽  
Dipeptidyl Peptidase ◽  
Phosphatidylinositol 3 Kinase ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Dependent Pathway ◽  
Phosphatidylinositol 3

The rats after myocardial infarction (MI) exposed to sitagliptin, a dipeptidyl peptidase-4 inhibitor, led to attenuated sympathetic innervation probably through a phosphatidylinositol 3-kinase and Akt-dependent pathway.

Cardioprotective Effects of Dipeptidyl Peptidase-4 Inhibitor on Diabetes Mice after Myocardial Infarction

2012 ◽  
Vol 18 (10) ◽  
pp. S179-S180
Author(s):  
Yoshihito Kameda ◽  
Hiroshi Hasegawa ◽  
Yuka Kobara ◽  
Akihiko Kubota ◽  
Hiroyuki Tadokoro ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Diabetes Mice ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Cardioprotective Effects

Linagliptin: A Novel Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor for Treatment of Type II Diabetes Mellitus

2011 ◽  
Vol 7 (5) ◽  
pp. 325-335 ◽  
Author(s):  
Somsuvra B. Ghatak ◽  
Devang S. Patel ◽  
Neeraj Shanker ◽  
Ambrish Srivastava ◽  
Shrikalp S. Deshpande ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Dipeptidyl Peptidase ◽  
Type Ii ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor
Sign in / Sign up

Export Citation Format

Share Document